These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Early transcriptional changes in cardiac mitochondria during chronic doxorubicin exposure and mitigation by dexrazoxane in mice. Vijay V; Moland CL; Han T; Fuscoe JC; Lee T; Herman EH; Jenkins GR; Lewis SM; Cummings CA; Gao Y; Cao Z; Yu LR; Desai VG Toxicol Appl Pharmacol; 2016 Mar; 295():68-84. PubMed ID: 26873546 [TBL] [Abstract][Full Text] [Related]
45. Short communication: transplacental nucleoside analogue exposure and mitochondrial parameters in HIV-uninfected children. Brogly SB; DiMauro S; Van Dyke RB; Williams PL; Naini A; Libutti DE; Choi J; Chung M; Gerschenson M AIDS Res Hum Retroviruses; 2011 Jul; 27(7):777-83. PubMed ID: 21142587 [TBL] [Abstract][Full Text] [Related]
46. Can dexrazoxane reduce myocardial injury in anthracycline-treated children with acute lymphoblastic leukemia? Silber JH Nat Clin Pract Oncol; 2004 Nov; 1(1):16-7. PubMed ID: 16264791 [No Abstract] [Full Text] [Related]
47. Cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review. Bryant J; Picot J; Levitt G; Sullivan I; Baxter L; Clegg A Health Technol Assess; 2007 Jul; 11(27):iii, ix-x, 1-84. PubMed ID: 17610809 [TBL] [Abstract][Full Text] [Related]
48. Cardiovascular disease in survivors of childhood cancer. Bansal N; Amdani SM; Hutchins KK; Lipshultz SE Curr Opin Pediatr; 2018 Oct; 30(5):628-638. PubMed ID: 30124579 [TBL] [Abstract][Full Text] [Related]
49. Mito-tempol and dexrazoxane exhibit cardioprotective and chemotherapeutic effects through specific protein oxidation and autophagy in a syngeneic breast tumor preclinical model. Dickey JS; Gonzalez Y; Aryal B; Mog S; Nakamura AJ; Redon CE; Baxa U; Rosen E; Cheng G; Zielonka J; Parekh P; Mason KP; Joseph J; Kalyanaraman B; Bonner W; Herman E; Shacter E; Rao VA PLoS One; 2013; 8(8):e70575. PubMed ID: 23940596 [TBL] [Abstract][Full Text] [Related]
50. Exposure to anthracyclines during childhood causes cardiac injury. Lipshultz SE Semin Oncol; 2006 Jun; 33(3 Suppl 8):S8-14. PubMed ID: 16781284 [TBL] [Abstract][Full Text] [Related]
51. Cardiac autonomic dysfunction in survivors of childhood acute lymphoblastic leukemia: The St. Jude Lifetime Cohort Study. Christoffersen L; Gibson TM; Pui CH; Joshi V; Partin RE; Green DM; Lanctot JQ; Howell CR; Mulrooney DA; Armstrong GT; Robison LL; Hudson MM; Ness KK Pediatr Blood Cancer; 2020 Jul; 67(7):e28388. PubMed ID: 32383821 [TBL] [Abstract][Full Text] [Related]
52. The 6-maleimidocaproyl hydrazone derivative of doxorubicin (DOXO-EMCH) is superior to free doxorubicin with respect to cardiotoxicity and mitochondrial damage. Lebrecht D; Geist A; Ketelsen UP; Haberstroh J; Setzer B; Kratz F; Walker UA Int J Cancer; 2007 Feb; 120(4):927-34. PubMed ID: 17131338 [TBL] [Abstract][Full Text] [Related]
53. Effect of Dexrazoxane on Left Ventricular Systolic Function and Treatment Outcomes in Patients With Acute Myeloid Leukemia: A Report From the Children's Oncology Group. Getz KD; Sung L; Alonzo TA; Leger KJ; Gerbing RB; Pollard JA; Cooper T; Kolb EA; Gamis AS; Ky B; Aplenc R J Clin Oncol; 2020 Jul; 38(21):2398-2406. PubMed ID: 32343641 [TBL] [Abstract][Full Text] [Related]
54. A cross-sectional follow-up study of physical morbidities, neurocognitive function, and attention problems in post-treatment childhood acute lymphoblastic leukemia survivors. Chiou SS; Lin PC; Liao YM; Yang P Kaohsiung J Med Sci; 2019 Jun; 35(6):373-378. PubMed ID: 30913362 [TBL] [Abstract][Full Text] [Related]
55. Acute and late toxicities of pirarubicin in the treatment of childhood acute lymphoblastic leukemia: results from a clinical trial by the Japan Association of Childhood Leukemia Study. Hori H; Kudoh T; Nishimura S; Oda M; Yoshida M; Hara J; Tawa A; Usami I; Tanizawa A; Yumura-Yagi K; Kato K; Kobayashi R; Komada Y; Matsuo K; Horibe K; Int J Clin Oncol; 2017 Apr; 22(2):387-396. PubMed ID: 27858183 [TBL] [Abstract][Full Text] [Related]
56. Sperm analysis of patients after successful treatment of childhood acute lymphoblastic leukemia with chemotherapy. Marquis A; Kuehni CE; Strippoli MP; Kühne T; Brazzola P; Pediatr Blood Cancer; 2010 Jul; 55(1):208-10. PubMed ID: 20310003 [TBL] [Abstract][Full Text] [Related]
57. Prevention of cardiotoxicity among survivors of childhood cancer. Hutchins KK; Siddeek H; Franco VI; Lipshultz SE Br J Clin Pharmacol; 2017 Mar; 83(3):455-465. PubMed ID: 27591829 [TBL] [Abstract][Full Text] [Related]
58. Cardiovascular disease in adult survivors of childhood cancer. Lipshultz SE; Franco VI; Miller TL; Colan SD; Sallan SE Annu Rev Med; 2015; 66():161-76. PubMed ID: 25587648 [TBL] [Abstract][Full Text] [Related]
59. Plasma Mitochondrial DNA--a Novel DAMP in Pediatric Sepsis. Di Caro V; Walko TD; Bola RA; Hong JD; Pang D; Hsue V; Au AK; Halstead ES; Carcillo JA; Clark RS; Aneja RK Shock; 2016 May; 45(5):506-11. PubMed ID: 26682947 [TBL] [Abstract][Full Text] [Related]
60. Late cardiac damage of anthracycline therapy for acute lymphoblastic leukemia in childhood. Prestor VV; Rakovec P; Kozelj M; Jereb B Pediatr Hematol Oncol; 2000; 17(7):527-40. PubMed ID: 11033728 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]